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The gram-negative anaerobic bacterium Bacteroides 
fragilis is an integral component of the normal 
gastrointestinal flora. This organism colo-
nizes the intestinal tract of essentially all 
mammalian species; in fact, B. fragilis has no 
known reservoir other than mammals. Ge-
nomic sequencing and biochemical analysis 
have revealed that in B. fragilis, an unprec-
edented proportion of the genomic DNA is 
dedicated to the production of capsular poly-
saccharides, which are important virulence fac-
tors in most extracellular bacterial   pathogens. 
Loci for at least eight B. fragilis capsular poly-
saccharides have been identifi   ed (1), and at 
least two of these capsular polysaccharides pos-
sess a zwitterionic charge motif (2). Studies 
of B. fragilis colonization of the gastrointesti-
nal tract in germ-free mice have identifi  ed one 
of the zwitterionic polymers, polysaccharide 
A (PSA), as the fi  rst bacterial product with a 
demonstrated ability to stimulate T cell lineage 
diff  erentiation of the mammalian immune sys-
tem (3). Indeed, it is the polysaccharide’s dual-
charge structural motif that appears to confer 
this ability (4, 5).
Toll-like receptors (TLRs) play a   critical 
role in early innate immunity by sensing the 
presence of microbial pathogens and initiating 
a response to clear them (6, 7). These recep-
tors, homologues of the Drosophila Toll gene, 
recognize the highly conserved structural motifs 
called pathogen-associated   molecular patterns 
(PAMPs) (8). Among the   pathogen-associated 
molecules encompassed by the designation 
PAMP are endotoxin (LPS), peptidoglycan, and 
other bacterial cell-wall components includ-
ing fl  agellin, bacterial DNA, and viral double-
stranded RNA. At least 11 TLRs and their 
distinct ligands have been identifi  ed so far in 
mammals (9). Among these receptors are TLR4, 
which is activated by most bacterial LPSes 
(10), and TLR2, which is activated by several 
bacterial products, including peptidoglycans, 
lipoproteins, mycobacterial   lipoarabinomannan, 
and atypical LPSes such as those found in 
Por  phyromonas (8, 11). TLRs signal primarily 
through an adaptor protein, MyD88 (12), al-
though some TLRs can signal through non–
MyD88-dependent pathways (13, 14); this 
signaling ultimately results in NF-κB–mediated 
gene transcription (15). In fact, all the   signaling 
pathways induce transcription of many immuno-
logically important genes, such as those encod-
ing for major histocompatibility complex MHC 
mole  cules (16), co-stimulatory  molecules (17), cyto-
kines, chemokines, and adhesion molecules (18). 
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It is through activation of these molecules that TLRs mediate 
infl  ammatory responses, coordinate   innate and adaptive im-
munity (19), prime naive T cells (20, 21), induce memory 
(22), and facilitate the elimination of pathogens (23).
Extensive research has been performed to elucidate the 
role of TLRs in innate and adaptive immunity and to iden-
tify ligands that can stimulate these receptors (24). Although 
many known TLR ligands contain carbohydrate moieties, it 
appears that the noncarbohydrate portion of these molecules 
(e.g., lipid A in LPS) is usually critical for TLR ligation 
and activation (25). The potential role of pure carbohy-
drates as ligands for TLRs remains largely uninvestigated, 
even though antibodies to TLR2 and TLR4 have been 
shown to inhibit B cell and macrophage activation induced 
by polysaccharide fractions isolated from cell cultures of 
Acanthopanax senticosus (26). Likewise, low molecular weight 
hyaluronic acid oligosaccharides produced during infl  amma-
tion, fragmented heparin sulfate, and glucuronoxylomannan 
have been reported to induce maturation of DCs through 
TLR4 (27, 28).
We have previously identifi  ed a mechanism by which 
PSA can stimulate the adaptive immune response by activa-
tion of CD4+ T cells through an MHC class II (MHCII)–
  dependent mechanism (29). Processing and presentation of PSA 
depend on the production of NO; MHCII presentation of 
processed polysaccharides does not occur in mice lacking the 
inducible NO synthase gene (iNOS−/−). In addition, MH-
CII and the co-stimulatory molecule CD86 are up-regulated 
upon PSA-mediated activation of APCs (30). Many of the 
immunologic events leading to PSA-mediated T cell activa-
tion (such as iNOS expression, MHCII presentation, co-
stimulation, and cytokine production) have been shown in 
other systems to be linked to TLR activation (16–18). 
Therefore, we sought to determine whether PSA can initiate 
the innate immune response in a TLR-dependent manner 
that is consistent with—or even complementary to—the 
role played by this polysaccharide (through MHCII) in the 
adaptive portion of the response.
In this paper we demonstrate that PSA activation of 
TLR2 not only mediates the release of proinfl  ammatory cy-
tokines and NO by APCs but also leads to NF-κB nuclear 
translocation in these cells. Consistent with this result, TLR2−/− 
and MyD88−/− bone marrow–derived DCs (BMDCs) fail to 
produce TNF-α when incubated with PSA. Optimal pro-
duction of IFN-γ by CD4+ T cells requires MHCII presen-
tation of PSA by BMDCs. However, when PSA is presented 
by TLR2−/− BMDCs, CD4+ T cell production of IFN-γ is 
considerably decreased. Furthermore, IFN-γ production is 
almost completely abolished when both the innate (TLR2) 
and adaptive (antigen-processing) arms of the immune response 
are rendered nonfunctional.
In vivo abscess formation after challenge with PSA or live 
B. fragilis has been shown to depend on a robust adaptive im-
mune response (30). We now demonstrate the additional re-
quirement for an intact innate signaling system for abscess 
formation, documenting an impaired abscess-forming ability 
in TLR2−/− mice. These data reveal a critical role for PSA 
signaling via TLR2 in coordinating the innate and adaptive 
immune responses.
RESULTS
PSA activates cytokine production by APCs via 
TLR2-dependent mechanisms
To begin elucidating the response of professional APCs to 
the B. fragilis polysaccharide antigen PSA, we examined the 
cytokine production profi  les of various APCs upon stimu-
lation with the carbohydrate PSA. PSA, Escherichia coli LPS 
(a TLR4 agonist), and the synthetic macrophage-activating 
lipopeptide 3 (MALP-3; a TLR2 agonist) were incubated 
with a mouse RAW 264.7 macrophage cell line or   primary 
mouse BMDCs. As shown in Fig. 1 A, TNF-α   production 
induced by PSA was comparable to that produced in response 
to MALP-3 and E. coli LPS in both cell types. Similarly, PSA 
induced substantial IL-12p40 secretion by BMDCs; how-
ever, macrophages failed to produce IL-12p40 in   response 
to any of the agonists tested. Poor IL-12 production by 
  macrophages was not a dose-related phenomenon: even very 
high doses of PSA did not induce IL-12 production in these 
cells (unpublished data). Induction of these cytokines by 
APCs appeared to be a unique function of PSA in that other 
polysaccharides−such as mannan, polygalacturonic acid, 
and type 1 Streptococcus pneumoniae capsular polysaccharide 
(Sp1)−failed to stimulate TNF-α or IL-12p40 production 
in either cell type (unpublished data). Results similar to those 
described with RAW 264.7 cells were obtained with fresh 
human monocytes, THP-1–derived macrophages, and fresh 
mouse peritoneal macrophages.
To establish a role for TLR2 signaling in PSA-induced 
activation of APCs, an inhibitory mAb to TLR2 was used in 
NF-κB translocation and cytokine production experiments. 
This mAb, raised against the extracellular domain of mouse 
TLR2, inhibits cell activation in experimental mouse models 
of infection and prevents TLR2-driven lethal shocklike syn-
dromes (31). Macrophages were preincubated with the mAb 
before the addition of stimuli to ensure complete blockage, 
and cytokine production was assessed 15 h after stimulation. 
At 15 h, TNF-α production was signifi  cantly reduced in 
PSA-stimulated cells preincubated with the anti-TLR2 mAb 
compared with cells treated with an isotype control antibody 
(P < 0.05; Fig. 1 B). Studies with the TLR2 agonist MALP-3 
showed a similar blockade of cytokine production by the 
anti-TLR2 mAb (31), whereas TNF-α production by LPS-
stimulated cells was unaff  ected by this mAb. Likewise, PSA-
mediated cytokine release was not reduced by preincubation 
with an anti-TLR4 mAb (unpublished data).
NF-κB is a critical nuclear transcription factor that regu-
lates many immune genes and cytokine responses (32). Vari-
ous inducers, such as LPS, result in the degradation of IκB 
protein and the release of NF-κB dimers that subsequently 
translocate to the cell nucleus and activate appropriate tar-
get genes. To determine whether PSA induces these events 
in activated APCs, we used a modifi  ed ELISA to measure JEM VOL. 203, December 25, 2006  2855
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NF-κB p65 (RelA) protein levels after PSA activation. RAW 
264.7 macrophages were incubated with PSA, MALP-3, 
LPS, and a medium control for various intervals, after which 
activation of NF-κB was measured. NF-κB p65 protein 
levels increased upon PSA stimulation, with peak activa-
tion at 1.5 h (unpublished data). Activation of NF-κB by 
PSA and MALP-3 was reduced back to the baseline level in 
the presence of the anti-TLR2 mAb, whereas LPS-induced 
activation of NF-κB was unaff  ected by blocking TLR2 
  activation (Fig. 1 C).
Engagement of TLRs by microbial products often re-
sults in TLR dimerization and subsequent recruitment of the 
adaptor molecule MyD88 (7); these events constitute one 
major pathway leading to NF-κB translocation and cyto-
kine production. We further investigated the role of TLR2 
and the adaptor protein MyD88 in PSA-mediated APC ac-
tivation. BMDCs were isolated from WT, TLR2−/−, and 
MyD88−/− mice. Upon PSA stimulation, TLR2−/− BM-
DCs produced lower levels of TNF-α and IL-12p40 than 
WT cells (P < 0.05; Fig. 1 D). Similar results were obtained 
with BMDCs isolated from MyD88−/− mice (P < 0.0001; 
Fig. 1 E). LPS-induced cytokine production was not aff  ected 
by the absence of TLR2 but was signifi  cantly impaired in 
MyD88−/− cells, as this signal transduction protein is  common 
to both TLR2 and TLR4 signaling pathways. These results 
establish a mechanism for PSA-induced activation of APCs 
through a TLR2-dependent mechanism, which requires 
  intact MyD88.
Cytokine production is TLR2 dependent
In further cytokine production studies of the role of PSA in 
TLR2 activation, we used cells with known TLR expression 
patterns. Human embryonic kidney (HEK)–293 cells, which 
do not normally express TLR2 or TLR4, were cotransfected 
with the human tlr2 or tlr4 gene and incubated with the carbo-
hydrate antigen (33, 34). PSA stimulation induced IL-8 pro-
duction by TLR2-expressing cells but not by TLR4-positive 
cells (Fig. 2 A). The unresponsiveness of TLR4-transfected 
cells to PSA confi  rmed the absence of E. coli LPS contamina-
tion in the PSA sample. The human astrocytoma cell line U373 
(35), which lacks the TLR2 receptor, failed to produce IL-6 
when stimulated with either PSA or the known TLR2 agonist 
MALP-3, whereas the TLR4 agonist E. coli LPS strongly in-
duced the release of IL-6 by this cell type (Fig. 2 B).
Figure 1.  B. fragilis PSA induces infl  ammatory responses in APCs 
via TLR2-dependent signaling. (A) RAW macrophages and BMDCs were 
incubated for 15 h with medium control, 100 μg/ml PSA, 20 nM MALP-3, 
or 100 ng/ml E. coli LPS. Levels of TNF-α and IL-12p40 in the cell superna-
tants were measured by ELISA. (B) RAW macrophages were preincubated 
with 50 μg/ml anti–mouse TLR2 mAb (clone T2.5) or 50 μg/ml IgG1 iso-
type control for 1 h before the addition of the following stimulants: 
100 μg/ml PSA, 20 nM MALP-3, or 100 ng/ml E. coli LPS. Production of 
TNF-α was assayed by ELISA after incubation for 15 h. (C) Preincubation 
of RAW macrophages with 50 μg/ml anti–mouse TLR2 mAb or 50 μg/ml 
isotype control was followed by incubation with 100 μg/ml PSA, 20 nM 
MALP-3, or 250 ng/ml E. coli LPS. NF-κB activation was measured in 
  antigen-activated cell extracts at 1.5 h. (D) BMDCs isolated from WT or 
TLR2−/− mice were incubated with 100 μg/ml PSA, 20 nM MALP-3, or 
100 ng/ml E. coli LPS. TNF-α and IL-12p40 production was measured by 
ELISA after incubation for 15 h. (E) In similar experiments, TNF-α produc-
tion by MyD88−/− and WT BMDCs was examined. Data represent mean ± 
SEM. *, P < 0.05.2856  B. FRAGILIS POLYSACCHARIDE LINKS INNATE AND ADAPTIVE IMMUNITY | Wang et al.
Using purifi  ed B. fragilis LPS, we confi  rmed that our ob-
servations with PSA were not due to contamination of the 
PSA preparation with this molecule. In experiments with 
TLR2-expressing HEK-293 cells, B. fragilis LPS at concen-
trations as low as 1 μg/ml (but not lower) results in IL-8 
  production. IL-8 release with B. fragilis LPS stimulation cor-
responds to that with PSA stimulation of 100 μg/ml (Fig. 
2 A). We examined the PSA preparation by SDS-PAGE with 
ProQ staining, which detects LPS at low-nanomolar concen-
trations. No B. fragilis LPS was detected in lanes loaded with 
a 10-mg/ml sample of PSA, a result indicating that LPS exists 
at a concentration of <100 ng/ml in a 100-μg/ml solution 
of polysaccharide. This concentration of B. fragilis LPS is an 
order of magnitude below the minimal TLR activation con-
centration in these cells (Fig. 2 A).
BMDCs from TLR2−/− mice take up PSA into their 
endosomal compartment
BMDCs from WT and TLR2−/− mice were incubated with 
fl  uorescently labeled PSA for 3 h to allow fl  uorescence up-
take by the APCs. Cells were then fi  xed and stained with 
MHCII-specifi  c mAbs, and cellular localization was assessed. 
Both WT and TLR2−/− BMDCs effi   ciently  endocytosed 
PSA (Fig. 3). PSA and MHCII colocalized within cells, a re-
sult indicating that PSA had entered the MHCII compart-
ment within the traditional class II pathway (Fig. 3, arrows).
PSA expressing a zwitterionic charge motif induces 
NO production through TLR2
When cells encounter microbes or foreign antigens, both 
reactive oxygen species and reactive nitrogen species are 
produced. This oxidative environment not only facilitates 
bacterial killing and degradation (36) but also enables APCs 
to process T cell–dependent carbohydrate antigens such as 
PSA for presentation by MHCII (29). We have previously 
shown that T cells from iNOS−/− mice cannot respond to 
PSA because of a defect in carbohydrate antigen process-
ing by their APCs. In these animals, PSA is not presented 
on the surface of the APCs in the presence of MHCII, and 
T cells are not activated. Consequently, abscess formation 
(which depends on T cell activation) does not occur in these 
animals (29).
Figure 2.  TLR2 is required for PSA activation. (A) HEK cells express-
ing TLR2 or TLR4/MD2 were incubated for 15 h with 1–1000 μg/ml PSA, 
1–1000 μg/ml B. fragilis LPS (BFLPS), 20 nM MALP-3, or 250 ng/ml E. coli 
LPS (ECLPS). Cell supernatants were assayed for IL-8 by ELISA. (B) Human 
U373 astrocytoma cells were incubated with 1 mg/ml PSA, 20 nM 
MALP-3, or 250 ng/ml E. coli LPS, and IL-6 levels were measured by ELISA. 
Data represent mean ± SEM.
Figure 3.  PSA is endocytosed by TLR2−/− BMDCs. BMDCs were in-
cubated for 3 h with fl  uorescent PSA (red) molecules. The cells were fi  xed 
and stained with a mAb specifi  c for MHCII protein (green). Both WT and 
TLR2−/− cells endocytosed PSA in a manner that resulted in colocalization 
(arrow, yellow) with MHCII protein. MHCII expression was not dependent 
on the presence of TLR2−/− under these conditions. Bars, 10 μm.JEM VOL. 203, December 25, 2006  2857
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To establish a link between the adaptive arm of the im-
mune response to PSA and our data demonstrating innate 
recognition of the same antigen, we examined whether PSA 
activation of TLR2 signaling can induce the expression of 
the iNOS gene. RAW macrophages were incubated with 
antigens for 8 h, and total mRNA was extracted and sub-
jected to RT-PCR analysis with gene-specifi  c primer sets. 
As shown in Fig. 4 A, transcription of the iNOS gene was 
substantially up-regulated in APCs after incubation with 
PSA. To confi  rm that increased transcription correlates with 
NO production, we monitored NO production by APCs in 
the presence and absence of blocking mAbs to TLRs using 
the Griess Reagent System to detect nitrite production. After 
stimulation for 15 h, the macrophages produced readily de-
tectable levels of NO, but this production was signifi  cantly 
reduced in the presence of anti-TLR2 mAb (P = 0.0002; 
Fig. 4 B). NO production stimulated by E. coli LPS was not 
aff  ected by this antibody.
It has been established that the positive charges from free 
amino groups in PSA are critical in PSA-induced T cell acti-
vation and abscess formation (2). To determine whether 
charge also plays a key role in the innate portion of the re-
sponse to PSA, we conducted cytokine and NO production 
assays using N-acetylated PSA molecules containing only 
negative charges. The elimination of positive charges in PSA 
resulted in reduced IL-8 production in TLR2-expressing 
HEK-293 cells (P = 0.0002 at 62.5 μg/ml incubation con-
centration; Fig. 4 C). Similar results were observed with 
RAW macrophages and BMDCs (unpublished data). Elimi-
nation of positive charges also resulted in signifi  cant reduc-
tions in NO production by RAW macrophages (P < 0.0001; 
Fig. 4 D). However, zwitterionic charge alone is not suffi   -
cient for polysaccharide stimulation of TLR activity: Sp1, 
which is a zwitterionic polysaccharide and contains a posi-
tively charged free amino group, failed to stimulate cytokine 
production by RAW macrophages (unpublished data).
PSA activation of both innate and adaptive immune 
responses contributes to antigen presentation and CD4+ 
T cell activation
TLR2 activation of NF-κB has been reported in other systems 
to result in the up-regulation of numerous molecules known 
to be important in PSA processing and presentation (e.g., NO, 
MHCII, and CD86) (9). We examined the role of TLR2 in 
the up-regulation of these molecules on BMDCs stimulated 
in vitro with PSA. PSA was incubated with BMDCs for 24 h, 
and CD11c+ cells were analyzed by fl  ow cytometry for ex-
pression of CD86 (B7-2) and MHCII (I-E/I-A). PSA-stimu-
lated WT BMDCs up-regulated CD86 expression by 82% 
and MHCII expression by 29%. BMDCs from TLR2−/− 
mice did not up-regulate these molecules (Table I).
We next examined the impact of TLR2 defi  ciency in 
APCs on naive T cell activation, measuring IFN-γ produc-
tion by WT CD4+ T cells coincubated with BMDCs derived 
Figure 4.  NO production is dependent on TLR2 activation by 
zwitterionic PSA. (A) RAW macrophages were incubated for 8 h with 
medium control, 100 μg/ml PSA, 200 nM MALP-3, or 100 ng/ml E. coli LPS. 
Total RNA was purifi  ed on an RNeasy column, and a 100-ng portion of 
each sample was subjected to RT-PCR using iNOS gene–specifi  c primers. 
GAPDH was used as a standard to normalize gene amplifi  cation. (B) RAW 
macrophages were incubated with or without 50 μg/ml anti-TLR2 mAb 
for 1 h before incubation with antigens. Nitrite production in the cell 
supernatants was measured at 15 h by the Griess Reagent System. 
(C) TLR2-expressing HEK-293 cells were incubated with PSA or N-acetylated 
PSA at different concentrations, and IL-8 production was assessed at 15 h. 
(D) RAW macrophages were incubated with increasing concentrations of 
PSA or N-acetylated PSA for 15 h, and NO production was measured by the 
Griess Reagent System. Data represent mean ± SEM. *, P < 0.05.2858  B. FRAGILIS POLYSACCHARIDE LINKS INNATE AND ADAPTIVE IMMUNITY | Wang et al.
from TLR2-suffi   cient and -defi  cient mice. When PSA was 
presented by TLR2−/− BMDCs, there was a considerable 
decrease in IFN-γ production by CD4+ T cells (Fig. 5). To 
ensure that the remaining IFN-γ production resulted from 
PSA presented via the MHCII pathway and not from stimu-
lation of another innate pathway, we treated both WT and 
TLR2−/− BMDCs with chloroquine, which prevents acidi-
fi  cation of the MHCII compartment vesicle—a crucial step 
in the MHCII antigen-processing pathway that is required to 
free the peptide-binding site on the MHCII molecule before 
peptide–MHCII interaction (37, 38). Compared with un-
treated co-cultures, those treated with chloroquine exhibited 
substantially reduced IFN-γ production by CD4+ T cells 
when PSA was presented by WT BMDCs. Blocking presen-
tation by TLR2−/− BMDCs almost completely eliminated 
IFN-γ production by CD4+ cells. Similar results were ob-
tained using the drug cytochalasin D, which inhibits cyto-
skeleton polymerization—a process that is necessary for the 
endocytosis of molecules into the APC before processing by 
the MHCII pathway (unpublished data). The superantigen 
staphylococcal enterotoxin A (SEA) induced comparable 
IFN-γ production by CD4+ cells after stimulation of either 
WT or TLR2−/− BMDCs; in addition, chloroquine treat-
ment did not aff  ect SEA-induced CD4+ cell activation, be-
cause SEA does not require intracellular processing by the 
APC before presentation by MHCII molecules (Fig. 5). Sim-
ilar experiments were performed using PSA-primed CD4+ T 
cells isolated from mice that had received repeated adminis-
tration of 50 μg PSA over a 2-wk period. IFN-γ production 
by these primed CD4+ T cells was greater than that seen by 
the naive cells after in vitro PSA stimulation in the presence 
of WT BMDCs only. TLR2−/− BMDCs induced minimal 
IFN-γ production even by the PSA-primed CD4+ T cells.
TLR2 is critical for PSA-dependent abscess formation
Abscess formation is a complex host response to bacterial 
  infection that requires several cell types. The activation of 
CD4+ T cells by zwitterionic polysaccharide (ZPS) antigens 
is one essential factor in the process (39). Using a model of 
intraabdominal abscess formation, we investigated whether 
this T cell–dependent process also depends on the initial 
  interaction of PSA with TLR2. We administered PSA or live 
B. fragilis bacteria i.p., along with an adjuvant of sterilized 
  cecal contents (SCC), to TLR4-hyporesponsive C3H/HeJ 
mice, TLR2−/− mice, and appropriate WT controls. WT and 
TLR4-hyporesponsive mice formed abscesses normally in 
  response to challenge with either PSA or B. fragilis (Fig. 6). 
In contrast, similarly challenged TLR2−/− mice exhibited a 
considerably reduced ability to form abscesses.
D  I  S  C  U  S  S  I  O  N 
Remarkably, each B. fragilis organism synthesizes at least eight 
distinct polysaccharides (PSA to PSH). The expression of 
seven of these polysaccharides is modulated by an intricate 
genetic mechanism that allows each polysaccharide to un-
dergo reversible phase variation (1). Phase variation of these 
surface polysaccharides guarantees the existence of a popula-
tion of organisms most fi  t to survive in the changing intestinal 
milieu by adapting to local conditions and stimulating local 
and systemic interactions with the host immune system.
Figure 5.  PSA stimulates IFN-𝗄 production by CD4+ T cells 
through activation of both innate and adaptive immune responses. 
BMDCs isolated from WT and TLR2−/− mice were co-cultured with WT 
CD4+ T cells for 24 h and stimulated with either PSA or SEA in the pres-
ence or absence of chloroquine, an inhibitor of antigen processing. IFN-γ 
production by the CD4+ T cells was measured by ELISA. Data represent 
mean ± SEM.
Figure 6.  TLR2 signaling is required for abscess formation in vivo. 
Groups (n = 8) of WT, TLR2−/−, or TLR4-hyporesponsive mice received an 
i.p. injection of sterilized cecal contents alone (SCC; 1:10 dilution, vol/vol) 
or in combination with 50 μg PSA per mouse or 108 CFU B. fragilis per 
mouse. 7 d later, the mice were examined for the presence of intraab-
dominal abscesses. The number of mice positive for abscesses in each 
group is shown.
Table I.  TLR2-mediated enrichment of CD86 and MHCII 
expression by PSA-stimulated BMDCs
Media 100 𝗍g/ml PSA
WT BMDCs CD86 18% 33%
MHCII 32% 42%
TLR2−/− BMDCs CD86 26% 24%
MHCII 42% 40%
BMDCs derived from either wild-type or TLR2−/− C57BL/6J mice were incubated for 
24 h with 100 μg/ml PSA or medium alone. The expression of the MHCII molecule 
and the co-stimulatory molecule CD86 was determined by fl  ow cytometry. The 
percentage of cells expressing either of these surface molecules is reported.JEM VOL. 203, December 25, 2006  2859
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The B. fragilis surface polysaccharides are involved in key 
interactions with the innate immune system. The innate im-
mune system plays a critical role in the maintenance of intes-
tinal epithelial homeostasis and in protection against intestinal 
injury and associated mortality (40). We now report that in-
nate immunity mediated by TLR2 signaling is critical for an 
optimal adaptive immune response to intestinal microbes, 
leading to the T cell activation that is essential for the devel-
opment of a proper Th1/Th2 cell balance in the mammalian 
immune system (3).
PSA is the most abundant polysaccharide of B. fragilis. Its 
zwitterionic charge motif is critical for its processing by APCs 
in a NO-dependent fashion through the MHCII pathway 
and its presentation to T cells (29). DCs and macrophages 
are two types of professional APCs that encounter and pres-
ent antigens originating in the intestine, as well as exogenous 
antigens found in the early stages of infection. Because these 
cells play a critical role in the development of T cell–mediated 
immune responses, it is important to understand the APC–
PSA interaction leading to the downstream signaling events 
that help to shape the host response to this carbohydrate.
We have identifi  ed TLR2 as a PSA receptor that plays a 
critical role in initiating the innate immune response through 
both the production of cytokines and the priming of the 
adaptive response to the polysaccharide. In this paper we 
show that PSA initiates a critical signaling cascade in APCs 
wherein the polysaccharide’s agonist eff  ect on APCs leads to 
several important biologic events, including (a) activation of 
the transcription factor NF-κB, (b) production of the proin-
fl  ammatory cytokine TNF-α, and (c) production of cyto-
kines and other molecules known to modulate the adaptive 
immune response (e.g., IL-12, CD86, MHCII, and NO). In 
studies eliminating TLR2 activation with antibodies or using 
TLR2−/− mice, we document reductions in PSA-induced 
NF-κB production and in the release of NO and proinfl  am-
matory cytokines. NF-κB activation by TLR2 is mediated 
via the MyD88 signaling pathway. These data suggest that 
TLR2 stimulation may facilitate NO-dependent polysaccha-
ride processing through up-regulation of NO production. In 
conjunction with NO up-regulation, TLR2-mediated sig-
naling results in up-regulation of MHCII and co-stimulatory 
molecule expression (CD86) by APCs, along with increases 
in the expression of the chemokine receptor CC chemokine 
receptor 7 (unpublished data). CC chemokine receptor 7 ex-
pression is associated with DC maturation and homing to the 
secondary lymphoid organs (41). Collectively, these TLR2-
mediated events appear to be important in maximizing the 
adaptive immune response to PSA by enhancing DC matura-
tion and antigen presentation.
IFN-γ is important in shaping the adaptive immune re-
sponse and is associated with driving Th1 cell–mediated im-
munity. We therefore examined whether PSA could induce 
CD4+ T cell activation and production of this cytokine ei-
ther through activation of innate immune signals or via the 
more classic adaptive immune pathway of MHCII-associated 
antigen presentation. Clearly, optimal induction of IFN-γ by 
CD4+ T cells depends on both arms of the immune system. 
PSA processing and presentation by the MHCII pathway was 
inhibited by treatment of APCs with either chloroquine or 
cytochalasin (29). Both drugs partially blocked IFN-γ pro-
duction by T cells upon PSA presentation by DCs. These 
fi  ndings substantiate our earlier report that MHCII-defi  cient 
DCs fail to induce IFN-γ production by CD4+ T cells in re-
sponse to PSA (3). However, we now demonstrate the in-
volvement of TLR2-mediated signaling by APCs in regulating 
IFN-γ production by T cells. Considerably less IFN-γ was 
produced by both naive and PSA-primed CD4+ T cells after 
in vitro PSA presentation by TLR2−/− DCs than after PSA 
presentation by WT DCs. Presumably, this decreased ability 
to activate CD4+ T cells is linked to a combination of re-
duced IL-12 signaling to the T cell from TLR2 knockout 
DCs and decreased presentation of PSA by the MHCII path-
way because of decreased NO production and decreased 
  expression of MHCII and CD86.
We have previously shown that PSA-induced IL-12 
production by DCs is vital for optimal IFN-γ production by 
T cells (3). IL-12 is a heterodimer that is composed of two 
subunits—p35 and p40—and is secreted by activated DCs. 
IL-12 signals through the IL-12R protein, which couples to 
the JAK–STAT signaling pathway—or, more specifi  cally, 
to transcription factors such as STAT4 (42). Recent experi-
ments have shown that a critical stage in Th1 cell diff  eren-
tiation from naive CD4+ T cells involves the transcription 
factor T-bet (T-box expressed in T cells). T-bet induces 
IL-12Rβ2 chain expression and allows IL-12/STAT4 sig-
naling to optimize IFN-γ production, which facilitates the 
Th1 cell developmental process (43). In addition, we have 
shown that blocking IL-12 production by APCs stimu-
lated with PSA can completely eliminate the production 
of IFN-γ by CD4+ T cells (3). We now demonstrate that 
PSA induces IL-12p40 production in DCs and that the in-
duction of IL-12p40 is substantially attenuated in TLR2−/− 
DCs. These data suggest that TLR2 is a critical receptor 
on DCs that can facilitate CD4+ T cell priming through 
IFN-γ   production in response to carbohydrate antigens, 
a process that ultimately leads to Th1 cell diff  erentiation. 
Interestingly, confocal microscopy (Fig. 3) revealed that PSA 
is taken up well into the endosomal compartment of TLR2-
defi  cient DCs. Therefore, TLR2 does not function as an 
uptake receptor for PSA despite its importance in stimulating 
T cell priming.
It is important to note that macrophages, unlike DCs, fail 
to produce the Th1 cell–stimulating cytokine IL-12 upon 
stimulation with PSA (Fig. 1 A). These cell type–dependent 
eff  ector functions may point to diff  erential expression of pat-
tern recognition receptors and coreceptors, as well as diff  er-
ent signal transduction cascades in the two types of APCs 
(44). The innate immune system reportedly uses a wide vari-
ety of microbial recognition receptors, including TLRs, lec-
tins, scavenger receptors, and integrins, to identify potential 
antigens (45–47). The outcomes of receptor ligation include 
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cytokines, and the development of adaptive immunity; yet, 
not all antigens induce these responses equally. Recently, it 
has been shown that DCs can diff  erentiate between self- and 
nonself-antigens through TLR engagement and that, on the 
basis of the antigen source, these cells can generate preferen-
tially presented peptide–MHC complexes from the contents 
of phagosomes derived from microbes (48). It has been 
  suggested that more than one receptor may be involved in 
antigen binding by TLRs (49, 50). For example, the C-type 
lectin dectin-1 cooperates with TLR2 to induce an infl  am-
matory response to zymosan (51). Given the diff  erential 
  cytokine production by DCs and macrophages in response to 
PSA-mediated TLR2-dependent stimulation, it is reasonable 
to suggest that distinct patterns of expression of various core-
ceptors on individual cell types are involved in shaping 
the overall response to PSA. Stimulation of TLR2 by PSA 
appears to be partially charge dependent. Elimination of 
  positively charged amine groups on PSA via N-acetylation 
reduces the production of IL-8, TNF-α, and NO by TLR2-
expressing HEK cells, DCs, and macrophages (Fig. 4, C and D). 
These observations support previous reports that the charges 
on PSA are critical for polysaccharide-mediated T cell activa-
tion (2). However, one important issue related to antigen 
structure is that the TLR2-mediated response of the APCs 
tested was not solely dependent on zwitterionic charge. Sp1, 
another T cell–activating ZPS, failed to activate TLR2. 
Therefore, the zwitterionic charge motif of PSA is necessary 
but not suffi   cient to induce TLR2-mediated APC activation. 
Specifi  c structure–function studies of PSA–TLR2 interaction 
are needed.
We show in this paper that both the innate and adaptive 
pathways of immunity are involved in at least one biologic 
response to PSA: intraabdominal abscess formation. TLR2-
defi  cient mice display a substantially reduced ability to form 
intraabdominal abscesses after challenge with either PSA or 
live bacteria along with SCC (Fig. 6). We have previously 
shown that mice with defects in antigen processing or pre-
sentation by the MHCII pathway are likewise unable to form 
abscesses (29). Interplay of the two arms of the immune sys-
tem may be required not only for an optimal response to PSA 
but also for other biologic functions of PSA, such as stimula-
tion of cell lineage diff  erentiation.
The identifi  cation of a critical role for TLR2 signaling in 
PSA-mediated activation of APCs adds an essential piece of 
information to our understanding of how this polysaccharide 
antigen stimulates the host immune response. On the basis of 
these data, we propose an integrated model for PSA-dependent 
activation of DCs and CD4+ T cells that involves consider-
able interplay of the innate and adaptive arms of the immune 
system (Fig. 7). In the innate portion of this response, PSA 
stimulates APCs through a TLR2-dependent mechanism. 
TLR2 activation then results in NF-κB–dependent NO pro-
duction, which is critical for PSA processing and presentation 
by MHCII and, thus, for initiation of the adaptive immune 
response. PSA-mediated TLR2 signaling also up-regulates 
MHCII and co-stimulatory molecule expression on the surface 
Figure 7.  Proposed model for the intersection of innate and 
adaptive immunity during polysaccharide-induced abscess forma-
tion in the peritoneal cavity. The innate response begins with TLR2 
recognition of PSA and the subsequent stimulation of the MyD88-
 mediated pathway inside the APC. NF-κB is translocated into the nucleus, 
stimulating the transcription of several important genes, including TNF-α. 
TNF-α is secreted by the APC and up-regulates intracellular adhesion 
molecule 1 on the mesothelium. Meanwhile, NF-κB translocation also 
leads to enhanced iNOS expression as well as up-regulation of MHCII 
and CD86, thus facilitating PSA processing and presentation by MHCII 
proteins. Presentation of PSA on the cell surface by MHCII leads to adap-
tive CD4+ T cell activation and T cell secretion of IFN-γ. IFN-γ produc-
tion by the T cell is optimized by TLR2-mediated IL-12 production by 
the dendritic cell. This fi  gure illustrates the interplay among innate sig-
nals and the shaping of the adaptive response for a common purpose: 
IFN-γ production.JEM VOL. 203, December 25, 2006  2861
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of APCs, further linking the innate and adaptive responses to 
this antigen. Upon antigen presentation by MHCII and rec-
ognition by αβ T cell receptors (along with co-stimulation), 
PSA-activated CD4+ T cells secrete IFN-γ. This process is 
enhanced by the production of the cytokine IL-12 by DCs, 
which occurs as a consequence of TLR2 stimulation. These 
experiments identify TLR2 as a major factor in initiating the 
host response required for optimal CD4+ T cell responses to 
PSA. Moreover, the results of these studies defi  ne a novel 
system that identifi  es the crucial interplay between the innate 
and adaptive arms of the host response.
MATERIALS AND METHODS
Animals and cell lines. Male 4–8-wk-old C57BL/6j, C3H/OuJ, and 
C3H/HeJ mice were maintained in a pathogen-free facility. Animal experi-
ments were performed in accordance with the guidelines of the Harvard 
Medical School Standing Committee on Animals.
HEK-293 cells were stably transfected with TLR2 or TLR4 (33, 34). 
Mouse RAW 264.7 macrophages and human THP-1 monocytes were 
obtained from the American Type Culture Collection. THP-1 cells were 
incubated with 100 ng/ml PMA for 3 d to obtain macrophages. Unless 
stated otherwise, cells were grown in a cell culture incubator at 37°C 
with 5% CO2.
Primary cell culture. BMDCs were cultured by previously described 
methods with minor modifi  cations (33). In brief, bone marrow was col-
lected from femurs and tibias of 8-wk-old WT, TLR2−/−, or MyD88−/− 
mice. Cells were resuspended in complete RPMI medium (American Type 
Culture Collection) containing 10 ng/ml GM-CSF (R&D Systems). After 
4 d of culture, cells were placed in fresh medium containing GM-CSF. On 
day 7, adherent and nonadherent cells were collected and seeded into 
  either 6- or 96-well culture plates, and experiments were performed the 
next day.
Bacteria and reagents. PSA was purifi  ed from a mutant strain of B. fragilis 
(∆44) according to a previously published method (52). No LPS was detect-
able in the PSA preparation by gel electrophoresis, 1H-NMR analysis, or 
endotoxin assay. PSA was modifi  ed with acetic anhydride in 0.1 M NaHCO3 
to obtain N-acetylated PSA.
E. coli LPS was purchased from Sigma-Aldrich and was further purifi  ed 
by phenol extraction A synthetic lipopeptide, MALP-3 (Pam3Cys-SKKKK), 
was purchased from EMC microcollections GmbH and was used as a TLR2 
agonist. Polysaccharide controls included mannan, polygalacturonic acid, 
and ZPS from Sp1.
RT-PCR. RAW 264.7 cells were plated at 5 × 105 in 3 ml of DMEM on 
sixwell plates 24 h before assay. Diff  erent antigens (100 μg/ml PSA, 20 nM 
MALP-3, and 250 ng/ml LPS) were added to corresponding wells, and plates 
were incubated for another 8 h. Total RNA was extracted with RNeasy 
columns (QIAGEN) according to the manufacturer’s protocol. RT-PCR 
was performed with gene-specifi  c primer sets for the GAPDH, iNOS, and 
TNF-α genes. 100 ng of total mRNA was subjected to one-step RT-PCR 
(SuperScript III; Invitrogen) and amplifi  ed (iCycler; Bio-Rad Laboratories). 
The primer sequences and sizes of PCR products were as follows: GAPDH, 
G  G  T  G  T  G  A  A  C  C  A  C  G  A  G  A  A  A  T  A   (forward) and CTGTTGCTGT  A  G  C-
C  G  T  A  T  T  C   (reverse; 569 bp) (1); iNOS, A  C  G  C  T  T  G  G  G  T  C  T  T  G  T  T  C  A-
C  T   (forward) and G  T  C  T  C  T  G  G  G  T  C  C  T  C  T  G  G  T  C  A   (reverse; 468 bp) (2); 
and TNF-α, A  G  C  A  C  A  G  A  A  A  G  C  A  T  G  A  T  C  C  G   (forward) and C  A  G  A  G  C-
A  A  T  G  A  C  T  C  C  A  A  A  G  T   (reverse; 702 bp) (3).
NO detection. NO production was quantifi  ed by measurement of the 
  accumulation of nitrite (NO2
−, a stable end product of NO) in cell culture 
supernatants with the Griess Reagent System (Promega).
NF-𝗋B detection. The production of NF-κB p65 (RelA) was measured 
with NF-κB assay kits (TransAm; Active Motif).
Confocal microscopy. Confocal microscopy was performed as previously 
described (29).
BMDC and CD4+ T cell co-culture experiments. For analysis of IFN-γ 
production by CD4+ T cells, T cells were isolated from spleens of C57BL/6J 
mice (The Jackson Laboratory) by centrifugation in Ficoll and were purifi  ed 
on CD4+ T cell enrichment columns (R&D Systems). BMDCs were 
  purifi  ed from the femurs of both C57BL/6J and TLR2−/− mice as described 
previously (33). For cytokine assays, 2 × 105 CD4+ T cells were combined 
with 105 BMDCs in 96-well round-bottom plates, and antigens and inhi-
bitor drugs were added. SEA and PSA were used at concentrations of 
10 ng and 100 μg, respectively. Preliminary dose–response experiments 
were conducted to determine the optimal concentration of each inhibitor 
drug, i.e., the lowest concentration that inhibited the endosomal pathway 
and was not toxic for the BMDCs. For inhibition experiments, 1 μM cyto-
chalasin D or 1 μg/ml chloroquine were added to the cells simultaneously 
with the antigens
Flow cytometry. BMDCs were incubated for 24 h with either 100 μg/ml 
PSA or culture media. Cells were then harvested and incubated with fl  uo-
rescent-conjugated mAbs to the cell surface markers CD86 (clone GL1) and 
I-A/I-E (clone M5/114.15.2; BD Biosciences) for 30 min at 4°C. Cells were 
washed and analyzed on a fl  ow cytometer (FC500; Beckman Coulter). 
  Appropriate isotype controls were included in each experiment.
ELISA. All cytokine ELISA kits, except the one for IL-12p40 (BD Biosci-
ences), were obtained from R&D Systems. 105 cells were seeded onto 96-
well fl  at-bottom plates 1 d before stimulation. Diff  erent concentrations of 
antigens (e.g., PSA, MALP-3, and LPS) were added to wells in triplicate 
(with a medium control), and plates were incubated for 15 h.
Mouse model of intraabdominal abscess formation. The intraabdomi-
nal abscess model used in these studies was based on that described in a previ-
ous publication (53).
Statistical analysis. Results are expressed as mean ± SD. Data were ana-
lyzed, as appropriate, by unpaired t tests with Prism software for Windows 
(version 3.00; GraphPad Software). Diff  erences were considered statistically 
signifi  cant at P < 0.05.
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